Jordan vs Maldives: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Jordan
0.0%
in 2025
Maldives
2.0%
in 2025
Jordan rank
165th
Maldives rank
164th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Jordan
- Maldives
How they compare
Maldives currently reports 2.0% against 0.0% in Jordan, a difference of 2.0%.
Across all 18 years both countries report, Maldives has been ahead every year.
Jordan ranks 165th and Maldives ranks 164th of 192 countries.
Maldives has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jordan | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 0.0% | 0.0% | 0.0% | β |
| 2020s | 0.0% | 0.3% | 0.3% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Jordan or Maldives?
- Maldives, at 2.0% against 0.0% in Jordan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Jordan and Maldives?
- 2.0%, with Maldives ahead.
- How many years of comparable data are there for Jordan and Maldives?
- 18 years are reported by both, from 2008 to 2025.
- How do Jordan and Maldives rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Jordan ranks 165th and Maldives ranks 164th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.